LabCorp
LHLH · Stock Price
Historical price data
Overview
LabCorp is a mission-driven, global leader providing vital information to guide healthcare decisions through two core, integrated segments: Diagnostic Laboratories and Drug Development. The company leverages its unparalleled scale—processing over 3 million tests daily and supporting over 75% of new FDA-approved drugs—to create a unique data and service flywheel. Its strategy centers on connecting diagnostic insights with clinical development expertise to improve patient outcomes and streamline the path from discovery to commercialization.
Technology Platform
An integrated technology ecosystem combining high-throughput laboratory automation, a proprietary real-world clinical database, AI-enhanced diagnostic tools (e.g., Test Finder), and global clinical trial management systems to connect diagnostic insights with drug development.
Pipeline
9| Drug | Indication | Stage | Watch |
|---|---|---|---|
| VIT-2763 60 mg QD + VIT-2763 60 mg BID + VIT-2763 120 mg BID... | Beta-Thalassemia | Phase 2 | |
| VIT-2763 once a day (QD) + VIT-2763 twice a day (BID) + Plac... | Beta-Thalassemia | Phase 2 | |
| EMB-01 | Neoplasms | Phase 1/2 | |
| EMB-01 + Osimertinib | Metastatic Lung Non-Small Cell Carcinoma | Phase 1/2 | |
| Infigratinib | Advanced Solid Tumor | Phase 1/2 |
